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raptor is a specific and essential component of mam-
malian TOR complex 1 (mTORC1), a key regulator of
cell growth and metabolism. To investigate a role of
adipose mTORC1 in regulation of adipose and
whole-body metabolism, we generated mice with an
adipose-specific knockout of raptor (raptorad/).
Compared to control littermates, raptorad/ mice
had substantially less adipose tissue, were protected
against diet-induced obesity and hypercholesterol-
emia, and exhibited improved insulin sensitivity.
Leanness was in spite of reduced physical activity
and unaffected caloric intake, lipolysis, and absorp-
tion of lipids from the food. White adipose tissue of
raptorad/ mice displayed enhanced expression
of genes encoding mitochondrial uncoupling pro-
teins characteristic of brown fat. Leanness of the
raptorad/ mice was attributed to elevated energy
expenditure due to mitochondrial uncoupling. These
results suggest that adipose mTORC1 is a regulator
of adipose metabolism and, thereby, controls whole-
body energy homeostasis.
INTRODUCTION
The protein kinase target of rapamycin (TOR) is a highly con-
served, central controller of cell growth and metabolism (Corra-
detti and Guan, 2006; Guertin and Sabatini, 2007; Wullschleger
et al., 2006). TOR is found in two functionally and structurally dis-
tinct multiprotein complexes termed TOR complex 1 (TORC1)
and TORC2 (Jacinto et al., 2004; Loewith et al., 2002; Sarbassov
et al., 2004). In mammals, mTORC1 consists of mTOR, raptor,
PRAS40, and mLST8 and is sensitive to rapamycin (Vander Haar
et al., 2007; Hara et al., 2002; Kim et al., 2002, 2003; Loewith
et al., 2002). mTORC2 contains mTOR, rictor, mSIN1, and mLST8
(Frias et al., 2006; Jacinto et al., 2004, 2006; Sarbassov et al.,
2004; Yang et al., 2006) and is not directly inhibited by rapamy-
cin, although long-term rapamycin treatment can inhibit
mTORC2 indirectly in certain cell types (Sarbassov et al., 2006).
As a central controller of cell growth, TOR plays a key role in
development and aging and is implicated in disorders such asCellcancer, cardiovascular disease, obesity, and diabetes (Guertin
and Sabatini, 2007; Wullschleger et al., 2006).
mTORC1 controls many cellular processes that ultimately
determine cell growth, including protein synthesis, ribosome
biogenesis, nutrient transport, and autophagy. The two best-
characterized substrates of mTORC1 are S6 kinase (S6K) and
4E-BP, via which mTORC1 controls protein synthesis (Beretta
et al., 1996; Brunn et al., 1997; Burnett et al., 1998; Hay and So-
nenberg, 2004). mTORC1 is controlled by metabolic cues, i.e.,
nutrients, cellular energy, and growth factors such as insulin or
IGF (Wullschleger et al., 2006). Although mTORC1 is present in
essentially all tissues, the findings that it is controlled by meta-
bolic signals and is implicated in metabolic disorders suggest
that it plays a particularly important role in metabolic tissues.
Thus, we have focused on studying the role of the mTORC1
signaling pathway in a metabolic tissue, in particular, adipose
tissue.
The traditional role of white adipose tissue (WAT) is as a long-
term fat storage depot for the body. However, it is also an impor-
tant endocrine organ that secretes hormones such as leptin,
adiponectin, TNFa, and many others (Gimeno and Klaman,
2005; Kershaw and Flier, 2004; Shi and Burn, 2004) that regulate
energy homeostasis, lipid metabolism, appetite, fertility, and im-
mune and stress responses. An excess or deficiency of adipose
tissue can lead to severe metabolic diseases such as type 2 dia-
betes, cardiovascular disorders, and cancer.
Adipose tissue also participates in the regulation of energy
homeostasis through adaptive thermogenesis. This occurs via
a type of adipose tissue known as brown adipose tissue (BAT),
which oxidizes fatty acids and dissipates energy as heat. Heat
production in BAT is achieved by short-circuiting, or uncoupling,
the mitochondrial proton gradient that is generated by the respi-
ratory chain. Uncoupling of the proton gradient from ATP
production in BAT is mediated by the BAT-specific uncoupling
protein 1 (UCP1). Two UCP1 homologs termed UCP2 and
UCP3 are also expressed in BAT, but these proteins are ex-
pressed at very low levels and it is less clear whether they trans-
fer protons and are, thus, indeed uncoupling proteins (Brand and
Esteves, 2005). Trans-differentiation between WAT and BAT
can be achieved, at least partly, via expression of specific tran-
scription factors. For example, expression of the transcription
factor PRDM16 (Seale et al., 2007), PGC1a (Puigserver et al.,
1998), RIP140 (Christian et al., 2005; Kiskinis et al., 2007; Leo-
nardsson et al., 2004), FOXC2 (Cederberg et al., 2001), p107
(Scime et al., 2005), or retinoblastoma (Hansen et al., 2004;Metabolism 8, 399–410, November 5, 2008 ª2008 Elsevier Inc. 399
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Adipose mTORC1 Controls Energy HomeostasisFigure 1. mTORC1 Is Required for Adipogenesis and Adipose Maintenance In Vitro
(A) Western blots showing the efficiency of raptor knockdown.
(B) 3T3-L1 preadipocytes were differentiated for 8 days and stained with oil red O. Rapamycin was added together with the differentiation mix and maintained
during the differentiation period. siRNA-encoding viruses were added 2 days before differentiation.
(C) Representative pictures of differentiated MEFs were taken from three knockout embryos and three wild-type littermates.
(D) 3T3-L1 preadipocytes were differentiated and then treated with rapamycin or isoproterenol (isoprot.) or left untreated for another 6 days, and triglyceride (TAG)
content was measured. Isoproterenol induces lipolysis and was used as a positive control. (n = 3, error bars represent SEM).
(E) 3T3-L1 preadipocytes were untreated or differentiated for 8 days. Differentiated cells were transduced with control or raptor siRNA-encoding viruses or
treated with rapamycin or isoproterenol for another 6 days. Lipids were visualized by oil red O staining. siRNA-mediated raptor knockdown in differentiated
3T3-L1 cells was efficient, as determined by western blot (data not shown).Scime et al., 2005) causes WAT cells to exhibit properties char-
acteristic of brown fat.
Several studies have suggested that mTORC1 is essential for
the differentiation and maintenance of adipocytes in vitro (Bell
et al., 2000; Cho et al., 2004; El-Chaar et al., 2004; Gagnon
et al., 2001; Kim and Chen, 2004; Yeh et al., 1995). To examine
the role of mTORC1 in adipose tissue in vivo, we generated
mice lacking the specific and essential mTORC1 component
raptor. Since a nonconditional, full-body knockout of raptor in
mice is embryonic lethal (Guertin et al., 2006), we generated con-
ditional raptor knockout mice using the cre/loxP system. These
mice were used to delete raptor specifically in adipose tissue.
We demonstrate that adipose raptor controls adipocyte metab-
olism and, thereby, full-body energy homeostasis.
RESULTS
mTORC1 Is Required for Adipogenesis and Adipose
Maintenance In Vitro
As shown previously, long-term rapamycin treatment prevents
adipogenic differentiation of 3T3-L1 cells in culture (Bell et al.,
2000; Cho et al., 2004; El-Chaar et al., 2004; Gagnon et al.,
2001; Kim and Chen, 2004; Yeh et al., 1995). Since long-term
rapamycin treatment can disrupt mTORC2 as well as inhibit400 Cell Metabolism 8, 399–410, November 5, 2008 ª2008 ElseviermTORC1 (Sarbassov et al., 2006), we genetically knocked
down raptor in undifferentiated 3T3-L1 preadipocytes to deter-
mine the role specifically of mTORC1 in adipogenesis (Figure 1A).
The cells in which raptor was knocked down were then treated to
induce adipogenesis and examined for lipid accumulation, by oil
red O staining (Figure 1B). Inactivation of mTORC1 by either ra-
pamycin treatment or knockdown of raptor prevented 3T3-L1
cells from differentiating into oil red O-staining cells, indicating
that mTORC1 is indeed required for adipogenesis. To test further
the requirement for mTORC1 in adipogenesis, we differentiated
heterozygous raptor+/mouse embryonic fibroblasts (MEFs) de-
rived from mice lacking one copy of the raptor gene (see Supple-
mental Experimental Procedures). Heterozygous MEFs were
used for this experiment because homozygous raptor knockout
MEFs could not be obtained due to very early embryonic lethal-
ity, as observed previously (Guertin et al., 2006). The raptor+/
MEFs differentiated into adipocyte-like cells but with signifi-
cantly reduced efficiency compared to MEFs from wild-type lit-
termates (Figure 1C), providing further support for a role of
mTORC1 in adipogenesis.
It has also been shown previously that culturing differentiated
3T3-L1 cells in the presence of rapamycin causes loss of fat,
suggesting that mTORC1 is also required for maintenance of ad-
ipocytes (Kim and Chen, 2004). We confirmed this observationInc.
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Adipose mTORC1 Controls Energy HomeostasisFigure 2. Generation and Validation of raptor Knockout
(A) Scheme describing the generation of raptor knockout.
(B) Western blot on epididymal WAT with raptor, S6K, mTOR, or actin antibodies as indicated, showing that the knockout was efficient.
(C) Western blots on epididymal WAT, inguinal WAT, BAT, liver, and soleus muscle with raptor or actin antibodies as indicated, showing that the knockout was
specific to adipose tissue.by measuring the triglyceride content of differentiated 3T3-L1
cells that were treated with rapamycin for 6 days after differenti-
ation. Differentiated 3T3-L1 cells that were incubated with
rapamycin for 6 days lost on average 46% of their triglyceride
content (Figure 1D). Rapamycin treatment or siRNA-mediated
raptor knockdown in differentiated 3T3-L1 adipocytes also
caused loss of lipid stores as visualized by oil red O staining
(Figure 1E). The above results confirm that mTORC1 is required
for both establishment and maintenance of mature adipocytes
in vitro.
Generation and Validation of Adipose-Specific
raptor Knockout Mice
To elucidate the role of mTORC1 in adipose tissue, we utilized
the cre/loxP system to generate mice in which raptor, an essen-
tial and specific component of mTORC1, is deleted exclusively in
adipose tissue. A ‘‘floxed’’ raptor allele was created in embryonic
stem cells of the 129S1/SvlmJ mouse strain by introducing
a loxP site into the introns flanking raptor exon 6, using a neo
cassette (G418 resistance) flanked by frt sites as a selectable
marker (Figure 2A). Stem cells in which homologous recombina-
tion had occurred were selected by G418 resistance, and re-
combination was confirmed by Southern blot analysis (data not
shown). The targeted stem cells were injected into blastocysts
of C57BL/6J mice to obtain chimeric floxed mice. After germline
transmission, the mice were crossed to C57BL/6J mice express-
ing flp recombinase to remove the neo cassette. Progeny con-
taining a floxed raptor allele lacking the neo cassette (raptorfl/+)
were further backcrossed to C57BL/6J mice. Mice used for all
phenotyping experiments had been backcrossed four or five
times. To knock out raptor, homozygous raptorfl/fl mice were
crossed with transgenic mice expressing cre recombinase under
control of the adipose-specific fabp4/aP2 gene promoter (aP2-
creTg/0) (He et al., 2003). Resulting raptorfl/+ aP2-creTg/0 progeny
were then crossed with raptor
fl/fl
mice to generate adipose-Cell Mspecific raptor knockout mice (raptorad/). Littermates lacking
the cre gene (raptorfl/fl) were used as controls.
Cre recombinase under control of the aP2 promoter is ex-
pressed relatively late inadipogenesis (Tontonoz etal., 1994), lead-
ing to knockout of raptor only in mature adipocytes. Thus, the gen-
erated raptorad/micecouldbeusedtostudy the roleofmTORC1
in the maintenance of mature adipocytes, but not in adipogenesis.
raptor protein and S6K phosphorylation (T389) were absent in
white and brown adipose tissue, but not in other tissues, of
raptorad/ mice (Figures 2B, 2C, and data not shown). We
also examined, by RT-PCR, expression of the cre recombinase
and confirmed that cre was expressed in white and brown
adipose tissue, but not in macrophages, liver, muscle, kidney, in-
testine, pancreas, or spleen (data not shown). Thus, raptorad/
mice lack raptor and are defective for mTORC1 signaling specif-
ically in adipose tissue.
raptorad/ mice were born at the expected Mendelian ratio.
raptorad/ females showed reduced fertility, giving birth on av-
erage to 3.9 ± 0.5 pups per litter, as compared to 6.79 ± 0.6 and
6.8 ± 0.5 pups per litter for floxed females that did not express
cre (raptorfl/fl) and for wild-type C57BL/6J females, respectively.
The time between litters was also slightly longer for raptorad/
females. raptorad/ males showed similar fertility to that of
raptorfl/fl and C57BL/6J males.
raptorad/ Mice Are Lean and Resistant
to Diet-Induced Obesity
As a first analysis of the effect of raptorad/ on adipose tissue,
we monitored the weight of raptorad/ mice and littermate
controls (raptorfl/fl) over 13 weeks between the ages of 8 and
21 weeks. On a chow diet, raptorad/ mice weighed 18% less
than raptorfl/fl mice (Figure 3A, left graph), but both gained weight
at a similar rate. After 13 weeks, both the raptorad/ and raptorfl/fl
mice had gained 33% of their initial weight. When challenged with
a high-fat diet (HFD), raptorad/mice initially gained weight moreetabolism 8, 399–410, November 5, 2008 ª2008 Elsevier Inc. 401
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Adipose mTORC1 Controls Energy HomeostasisFigure 3. Knockout Mice Are Lean and Resistant to Diet-Induced Obesity
(A) Mice (8-week-old) were fed a chow or HFD for 13 weeks. Body weight was monitored biweekly (n = 15–20).
(B) Representative pictures of mice after 13 weeks on an HFD.
(C) Weight of epididymal WAT, inguinal WAT, BAT, liver, kidney, and heart was measured in 21-week-old mice (n = 13–18 for chow diet, n = 6–9 for HFD).
(D) Representative pictures of fat pads and heart from mice that were on an HFD for 13 weeks.
(E) (Top) Representative pictures of H&E staining of epididymal WAT sections from raptorfl/fl and raptorad/ mice fed a chow or HFD. (Bottom) Quantification of
WAT cell circumference (n = 7–10). In all panels, error bars represent SEM.rapidly than control raptorfl/fl mice (Figure 3A, right graph). How-
ever, while the control mice continued to gain weight throughout
the time course of the experiment, raptorad/ mice gained little
to no weight after the initial 2–3 week period on the HFD. After
13 weeks on the HFD, raptorfl/fl mice had gained 85% of their
starting weight, whereas raptorad/ mice had gained only 41%
of their starting weight (Figures 3A and 3B).
To determine the cause of the reduced body weight of
raptorad/ mice, we examined individual fat pads and organs.
The major fat pads of raptorad/ mice were significantly lighter
and smaller than those of raptorfl/fl mice (Figures 3C and 3D).
This difference in the fat pads was more pronounced for the
mice on an HFD (Figures 3C and 3D). HFD-fed raptorad/ mice
had 70% less WAT than similarly fed raptorfl/fl mice (Figure 3C).
The knockout and control mice displayed no significant differ-
ence in the weight of lean organs, such as the liver, kidney,
spleen, and heart, on either the chow or high-fat diet (Figures
3C and 3D), indicating that the effect of the knockout was specific
to adipose tissue. This adipose-specific effect of the knockout
was confirmed by DEXA scan analysis, which also showed that
bone mass was unaltered in raptorad/ mice (data not shown).
Thus, an adipose-specific knockout of mTORC1 results in leaner
mice and confers resistance to diet-induced obesity.
raptorad/ Mice Have Smaller and Fewer WAT Cells
To determine whether the reduced amount of fat in raptorad/
mice is due to fewer fat cells and/or smaller fat cells, we measured402 Cell Metabolism 8, 399–410, November 5, 2008 ª2008 Elsevierthe circumference of individual adipocytes in epididymal WAT of
raptorad/ and raptorfl/fl mice (Figure 3E). The adipocytes from
knockout and control mice on a chow diet were similar in size, sug-
gesting that the lower amount of WAT in raptorad/mice is due to
fewer adipocytes. This finding was confirmed by FACS analysis,
which showed that epididymal WAT of raptorad/mice contained
approximately three times fewer cells than WAT of raptorfl/fl mice
(data not shown). Adipocytes from raptorfl/fl mice on a high-fat diet
displayed an expected 2-fold increase in size (Kubota et al.,
1999; Lemonnier, 1972), whereas adipocytes from raptorad/
mice on an HFD displayed only a slight increase in size. Calculat-
ing and comparing the volumes of adipocytes from raptorfl/fl and
raptorad/mice on an HFD indicated that raptorad/ adipocytes
were approximately half the size of the raptorfl/fl adipocytes.
Although raptorad/ adipocytes were significantly smaller, this
decrease was not sufficient to account for the observed overall re-
duction in adipose tissue (Figure 3C), indicating again that a raptor
knockout also reduces adipocyte number. The reduced weight of
a raptor knockout mouse is due to a combination of smaller and
fewer WAT cells. There was no obvious morphological difference
in BAT due to either diet or raptor knockout (data not shown),
although the raptorad/ mice contained less overall BAT. Thus,
mTORC1 is required to maintain adipose tissue.
raptorad/ Mice Have Better Metabolic Parameters
We next investigated the effect of the raptor knockout on whole-
animal metabolism. First, we performed an IP glucose toleranceInc.
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(A) IP glucose tolerance test (n = 7–10).
(B and C) Insulin and adiponectin plasma values (n = 10).
(D–G) Representative western blots on epididymal WAT, soleus muscle, or liver with the indicated antibodies (n = 5). A femto maximum sensitivity substrate (ECL)
kit was used to detect basal levels of Akt-pS473 phosphorylation in Figure 4G.
(H) Cholesterol plasma values (n = 10).
(I) Representative pictures of oil red O and hematoxylin staining of liver sections from raptorfl/fl and raptorad/ mice fed a chow or HFD.
(J) Quantification of triglyceride content (n = 10). In all panels, error bars represent SEM.test to determine the ability of the mice to clear glucose from the
blood (Figure 4A). On a chow diet, the basal glucose level of the
raptorad/mice was lower than that of raptorfl/fl mice (4.72 ± 0.3
versus 6.36 ± 0.52 mM, respectively). Upon IP injection of
glucose, the knockout mice had a normal glucose response
and clearance rate. On the HFD, basal glucose levels were, as
expected, higher than on the chow diet but slightly lower in
raptorad/ mice compared to raptorfl/fl mice. HFD-fed
raptorad/ and raptorfl/fl mice both exhibited reduced rates of
glucose clearance. However, the glucose clearance rate of the
raptorad/ mice was markedly better compared to the raptorfl/fl
mice, indicating that the knockout mice were more glucose toler-
ant than control mice. We then determined plasma insulin levels.CellThe fasting insulin levels were lower in raptorad/ mice com-
pared to raptorfl/fl mice (Figure 4B). The lower insulin level
combined with the observed lower basal glucose level and better
glucose clearance rate suggest that raptorad/ mice are more
insulin sensitive, despite lower adiponectin plasma levels
(Figure 4C).
To determine whether insulin signaling is indeed enhanced in
raptorad/ mice, we examined the effect of insulin stimulation
on Akt phosphorylation (T308 and S473) in WAT, muscle, and
liver of raptorfl/fl and raptorad/ mice. As expected, upon insulin
stimulation, Akt was phosphorylated in all tissues (Figures 4D–
4F). Akt phosphorylation was similar in WAT and liver of
raptorfl/fl and raptorad/ mice, indicating that insulin signalingMetabolism 8, 399–410, November 5, 2008 ª2008 Elsevier Inc. 403
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Akt was hyperphosphorylated in muscle in raptorad/ mice
compared to raptorfl/fl mice, indicating that insulin signaling is en-
hanced in muscle of raptorad/ mice. Thus, the lower basal glu-
cose level and better glucose clearance rate of the knockout
mice are likely due to improved insulin signaling and glucose up-
take by muscle. In this context, it is important to note that muscle
is the major insulin-stimulated glucose-consuming tissue.
Prolonged stimulation of mTORC1 and S6K inhibits upstream
signaling by the insulin pathway (including Akt), thereby forming
a negative feedback loop (Dowling et al., 2007; Harrington et al.,
2004; Krebs et al., 2007; Shah et al., 2004; Tzatsos and Kandror,
2006; Ueno et al., 2005; Um et al., 2004). To investigate the effect
of raptorad/ on this negative feedback loop, we examined Akt
and S6K phosphorylation in WAT of HFD-fed raptorad/ and
raptorfl/fl mice. HFD-fed control mice (raptorfl/fl) exhibited S6K
hyperphosphorylation and Akt hypophosphorylation, indicating
that an HFD activates the negative feedback loop in WAT (Fig-
ure 4G). raptorad/ eliminated the HFD-induced negative feed-
back loop, as indicated by loss of S6K hyperphosphorylation and
restoration of Akt phosphorylation (Figure 4G). Thus, the en-
hanced insulin sensitivity of the raptorad/ mice on HFD could
also be due to loss of negative feedback in adipose tissue. In
agreement with previous data (Aguilar et al., 2007), we also ob-
served increased AMPK phosphorylation in WAT of raptorad/
mice compared to raptorfl/fl mice (Figure 4G), which could also
contribute to higher insulin sensitivity. Taken together, the above
results suggest that raptorad/ mice are more insulin sensitive
due to enhanced insulin signaling in muscle and, on an HFD, in
WAT.
Plasma levels of cholesterol showed a similar trend as ob-
served for glucose tolerance (Figure 4H). Levels were similar
for the raptorad/ and raptorfl/fl mice on the chow diet and
were substantially increased for raptorfl/fl mice on the HFD. How-
ever, raptorad/mice maintained normal cholesterol levels even
on the HFD. The raptor knockout had no effect on plasma levels
of triglycerides and free fatty acids on either the chow or high-fat
diet (data not shown). Taken together, the above results suggest
that inactivation of mTORC1 in adipose tissue improves whole-
animal metabolism, in particular when mTORC1-deficient mice
are challenged by an HFD.
As described above, the raptorad/ mice displayed reduced
adiposity. Since an alteration in fat metabolism often results in
aberrant accumulation of fat in the liver (steatosis), we examined
the livers of the knockout and control mice by oil red O staining
and quantification of liver triglyceride content (Figures 4I and 4J).
On the chow diet, there was a small but significant reduction in
the amount of triglycerides stored in livers of raptorad/ com-
pared to raptorfl/fl mice. The HFD caused extensive and similar
hepatic steatosis in raptorad/ and raptorfl/fl mice.
Food Intake or Absorption, Physical Activity,
Adipose-Specific Lipolysis, or Expression of Fat Genes
Do Not Account for the Leanness of raptorad/ Mice
What is the underlying mechanism that causes raptorad/ mice
to be lean and resistant to diet-induced obesity? Adipose tissue
is an endocrine organ that interacts with other metabolic organs
to regulate behavior and whole-body metabolism. The observed
leanness could, therefore, be due to the interaction of adipose404 Cell Metabolism 8, 399–410, November 5, 2008 ª2008 Elsevier Intissue with other organs. To examine this possibility, we first
measured feeding behavior. raptorad/ and raptorfl/fl mice con-
sumed similar amounts of calories per day on both the chow and
high-fat diets (Figure 5A). Similar food intake occurred despite
markedly reduced plasma leptin levels in raptorad/ mice, sug-
gesting enhanced leptin sensitivity (Figure 5B). The reduced lep-
tin levels in raptorad/ mice are in agreement with the observed
reduction in WAT mass (Figure 3C), as leptin levels correlate with
WAT mass (Considine et al., 1996). Second, we investigated
voluntary locomotor activity of raptorad/ and raptorfl/fl mice.
Surprisingly, raptorad/ mice were less active than raptorfl/fl
mice, as measured by activity on running wheels. On average,
raptorad/ mice ran 2000 m/day, whereas raptorfl/fl mice
ran4500 m/day (Figure 5C). Third, we examined fecal lipid con-
tent to determine whether the observed leanness could be due to
a defect in food absorption. There was no difference in the fecal
lipid content of raptorad/ and raptorfl/fl mice (Figure 5D), indi-
cating that raptorad/ mice did not have a defect in absorption
of lipid from food. Thus, the leanness of raptorad/ mice is
not due to decreased food intake, increased physical activity,
or reduced lipid absorption.
An adipose maintenance defect could also be due to in-
creased lipolysis or dedifferentiation resulting from decreased
expression of adipose-specific fat storage genes. To test these
possibilities, we first measured lipolysis in differentiated 3T3-
L1 cells treated or untreated with rapamycin (Figure 6A) and in
epididymal WAT pads of raptorad/ and raptorfl/fl mice (Fig-
ure 6B). In neither system did we detect a significant difference
Figure 5. Food Intake, Leptin Levels, Voluntary Activity, and Fecal
Lipid Content
(A) Mice (8-week-old) were fed a chow or HFD for 13 weeks. Food intake was
measured biweekly (n = 15–20).
(B) Leptin plasma values (n = 10).
(C) Measurement of voluntary activity (n = 5–7).
(D) To measure lipid absorption in the digestive system, feces were collected
over 24 hr, and fat was separated by methanol:chloroform extraction.
Extracted lipids were weighed, and the percentage of feces fat (W/W) was
calculated (n = 7–11). In all panels, error bars represent SEM.c.
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Adipose mTORC1 Controls Energy HomeostasisFigure 6. Lipolysis, Respiratory Exchange Ratio, and Gene Expression Analysis
(A) 3T3-L1 cells were differentiated and then treated or not with rapamycin for the indicated periods of time. Glycerol release was measured during the last 30 min
(n = 4–6).
(B) Glycerol release was measured from epididymal WAT that was isolated and incubated in DMEM for 12 hr (n = 7).
(C) The respiratory exchange quotient was calculated as CO2 production/O2 consumption during indirect calorimetry measurements.
(D) 3T3-L1 cells were differentiated and then treated or not with rapamycin for the indicated periods of time. Gene expression levels were measured by qPCR on
cDNA (n = 3–5). All genes were normalized to actin. p% 0.01 for all genes except aP2 on day 6.
(E) Epididymal WAT was isolated, and gene expression levels were measured by qPCR on cDNA (n = 9 or 10). In all panels, error bars represent SEM.in glycerol release from the cells upon inactivation of mTORC1.
Finally, we determined the respiratory exchange ratio of
raptorad/ and raptorfl/fl mice as a measure of the utilized energy
source. As expected, HFD-fed mice had a lower ratio than chow-
fed mice, indicating greater utilization of fat versus carbohy-
drates as an energy source. However, the raptorad/ and
raptorfl/fl mice had a similar ratio (Figure 6C), indicating similar
utilization of carbohydrates and fat as energy sources. These
results suggest that the leanness of raptorad/ mice is not due
to enhanced lipolysis.
We then analyzed the expression pattern of several well-
known adipose-specific genes that mediate fat storage, in par-
ticular the genes encoding the transcription factors PPARg,
CEBPa, and SREBP and the genes encoding fatty acid-binding
protein aP2, fatty acid synthase (FAS), lipoprotein lipase (LPL),
resistin, and hormone-sensitive lipase (HSL). In 3T3-L1 cells, in-
hibition of mTORC1, either by rapamycin treatment or by raptor
siRNA, caused a significant decrease in all genes examined (Fig-
ure 6D), suggesting that inactivation of mTORC1 causes mature
adipocytes to ‘‘dedifferentiate’’ due to lack of expression of the
genes necessary for lipid production and storage. These results
are in agreement with a previous study that showed that the ac-
tivity of PPARg is reduced following rapamycin treatment (Kim
and Chen, 2004). However, unexpectedly, similar expression
levels were detected for the genes listed above in epididymal
WAT derived from raptorad/ and raptorfl/fl mice (Figure 6E).
This result suggests that, although inactivation of mTORC1 leadsCell Mto a similar phenotype in cell culture and mice, i.e., loss of fat, the
underlying molecular mechanism for this phenotype is probably
more complex in vivo, where interactions between many different
cell types and other external factors determine WAT metabolism.
However, the leanness of raptorad/mice appears not to be due
to changes in expression of common lipid metabolizing genes.
Macrophage infiltration into WAT increases with obesity
(Weisberg et al., 2003) and contributes to the secretion of inflam-
matory cytokines that are associated with changes in insulin sen-
sitivity and other metabolic parameters (Weisberg et al., 2006; Xu
et al., 2003). To determine the extent of macrophage infiltration
into the epididymal WAT of raptorad/ and raptorfl/fl mice, we
measured the expression level of mac1, a macrophage marker,
in cDNA extracts made from WAT (including any infiltrated mac-
rophages). As expected, mac1 expression was increased in
response to an HFD and the resulting obesity. However, there
was little to no difference in mac1 expression between
raptorad/ and raptorfl/fl mice on either a chow or high-fat diet
(data not shown). Thus, leanness was not due to a change in me-
tabolism resulting from a difference in macrophage infiltration.
raptorad/ Mice Have Higher Energy Expenditure Due
to an Increase in Uncoupled Respiration in WAT
Leanness of the raptorad/ mice could be due to increased en-
ergy expenditure. To investigate energy expenditure, we mea-
sured oxygen consumption by indirect calorimetry. raptorad/
mice displayed an increase in oxygen consumption as comparedetabolism 8, 399–410, November 5, 2008 ª2008 Elsevier Inc. 405
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(A) O2 consumption by 14-15 week old mice that remained on chow or HFD during the previous 5-6 weeks.
(B) O2 consumption in primary white adipocytes isolated from raptor
fl/fl or raptorad/ mice (n = 4), as measured with a Clark electrode. O2 consumption was
normalized to the amount of genomic DNA (gDNA).
(C and D) Epididymal WAT or BAT were isolated, and gene expression levels were measured by qPCR on cDNA (n = 9 or 10). In all panels, error bars
represent SEM.to raptorfl/fl mice (Figure 7A), suggesting that the knockout mice
indeed expend more energy. We then analyzed, using a Clark
electrode, the oxygen consumption by isolated white adipocytes
derived from raptorad/ and raptorfl/fl mice. Adipocytes from
raptorad/ mice displayed a significant increase in oxygen con-
sumption compared to control adipocytes (Figure 7B). Thus,
raptorad/ causes an increase in mitochondrial respiration in
WAT.
Why is respiration increased in WAT of raptorad/ mice? The
observed increase in oxygen consumption by isolated adipo-
cytes, as described above, was abolished by the addition of
ADP (data not shown). This effect of ADP, which stimulates cou-
pled respiration and inhibits uncoupled respiration (Nicholls,
2001), suggested that the increase in oxygen consumption could
be due to uncoupled mitochondrial respiration. To investigate
this possibility further, we examined expression of mitochondrial
uncoupling genes in WAT from raptorad/ and raptorfl/fl mice.
We observed a strong increase (25-fold) in the expression of
the uncoupling protein 1 (UCP1) gene and, to a lesser extent,
in expression of UCP2 and other brown fat markers such as
type 2 deiodinase (dio2) and cidea in WAT of raptorad/ mice406 Cell Metabolism 8, 399–410, November 5, 2008 ª2008 Elsevier In(Figure 7C). Thus, the leanness of raptorad/ mice appears to
be due to increased energy expenditure resulting from mito-
chondrial uncoupling in WAT. Surprisingly, we also detected
a small increase (3-fold) in UCP1 expression in skeletal muscle
of raptorad/ mice. This increase might also contribute to the
leanness of raptorad/ mice.
No difference in oxygen consumption was detected in brown
adipocytes isolated from raptorad/ and raptorfl/fl mice (data
not shown). In agreement with this finding, the level of UCP1 ex-
pression in BAT was unaffected by raptor knockout (Figure 7D),
although expression of PPARg, as well as UCP2 and UCP3, was
reduced (Figure 7D). It remains to be determined why BAT mass
is reduced in raptorad/ mice.
DISCUSSION
Here, we describe the generation and phenotypic characteriza-
tion of conditional raptor knockout mice. Knockout of raptor spe-
cifically in adipose tissue (raptorad/) results in mice that are
lean and resistant to diet-induced obesity. raptorad/ mice
also exhibit an overall better metabolic profile than controlc.
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diet-induced hypercholesterolemia. Furthermore, we present
evidence that the leanness of raptorad/mice is due to elevated
energy expenditure as a consequence of uncoupled mitochon-
dria in white adipose tissue. These results suggest that mTORC1
in adipose tissue plays an important role in the control of both
adipose metabolism and whole-body energy homeostasis.
Similar to adipose-specific raptor knockout, whole-body
knockout of S6K1, which is positively regulated by mTORC1,
results in lean mice that are resistant to diet-induced obesity
due to increased energy expenditure (Pende et al., 2000; Um
et al., 2004). Furthermore, S6K1 knockout mice exhibit normal
food intake despite lower leptin levels, smaller WAT cells, and
enhanced insulin sensitivity. Conversely, knockout of 4E-BP1
and 4E-BP2, which are negatively regulated by mTORC1, results
in increased obesity and hypersensitivity to diet-induced obesity
due to lower energy expenditure (Le Bacquer et al., 2007). This
remarkable correlation between adipose-specific knockout of
mTORC1 and full-body knockout of its direct effectors S6K1
and 4E-BP1/2 suggests that at least part of the effects of
the S6K1 and 4E-BP1/2 knockouts are via adipose tissue.
This, in turn, provides further evidence that mTORC1 signaling
in adipose tissue plays a central role in controlling whole-animal
metabolism.
raptorad/ mice have lower basal glucose levels, improved
glucose clearance, and reduced plasma insulin levels compared
to control raptorfl/fl mice, indicating that raptorad/ mice have
enhanced insulin sensitivity. We find that this enhanced insulin
sensitivity is due, at least in part, to increased insulin signaling
in muscle and, on a high-fat diet, in adipose tissue. This under-
scores the role of adipose and, in particular, adipose mTORC1
in controlling whole-body energy homeostasis. The increased
insulin signaling in adipose tissue is due to loss of the negative
feedback loop within the mTORC1 pathway. It remains to be
determined how mTORC1 signaling in adipose tissue controls
insulin sensitivity in other tissues.
Previous studies on the role of mTORC1 in mitochondrial func-
tion have provided seemingly conflicting results. Observed
changes in respiration by full-body S6K1 or 4E-BP1/2 knockout
mice suggest, in line with our results, that mTORC1 negatively
controls mitochondrial respiration (or uncoupling) (Le Bacquer
et al., 2007; Um et al., 2004). In contrast, muscle-specific knock-
out of raptor results in decreased oxidative capacity and mito-
chondrial gene expression (Bentzinger et al., 2008 [this issue of
Cell Metabolism]). Furthermore, rapamycin treatment or knock-
down of mTOR or raptor in muscle cells or in TSC knockout
MEFs decreases mitochondrial gene expression and oxygen
consumption (Cunningham et al., 2007). These latter effects
are via downregulation of PGC1a and the transcription factor
YY1 and do not involve S6K1 or Akt (Cunningham et al., 2007;
Schieke et al., 2006). Taken together, our data and the above
findings suggest that mTORC1 controls mitochondrial respira-
tion either negatively or positively depending on the mTORC1 ef-
fectors that might be found in a particular tissue.
Impaired TORC1 signaling in yeast, flies, and worms extends
lifespan (Kaeberlein et al., 2005; Kapahi et al., 2004; Powers
et al., 2006; Vellai et al., 2003). Inhibition of TOR signaling mimics
nutrient deprivation, and the extension of lifespan by TOR inhibi-
tion might, thus, be equivalent to the extension of lifespan by di-Cell Metary restriction. In this context, it is interesting to note that
raptorad/ mice have improved metabolic parameters that
could lead to extended lifespan. Furthermore, raptorad/
enhances respiration, and, at least as shown in budding yeast,
impaired TORC1 signaling extends lifespan by increasing mito-
chondrial respiration among other effects (Bishop and Guarente,
2007; Bonawitz et al., 2007; Kaeberlein and Powers, 2007). It
would be of interest to determine whether mTORC1 in mammals
and, in particular, in adipose tissue controls lifespan.
Metformin is a widely prescribed antidiabetic drug that in-
creases insulin sensitivity and lowers blood glucose and lipid
levels. It functions through activation of the LKB1-AMPK
pathway in liver (Shaw et al., 2005; Tzatsos and Kandror,
2006). Metformin also inactivates mTORC1 downstream of
AMPK (Dowling et al., 2007; Gwinn et al., 2008; Shaw et al.,
2004; Tzatsos and Kandror, 2006). Given that adipose-specific
knockout of mTORC1 increases insulin sensitivity and lowers
blood glucose and cholesterol levels, metformin might also exert
part of its therapeutic effect via activation of AMPK and inhibition
of mTORC1 in adipose tissue. It is also interesting to note that
rapamycin treatment in humans and rats prevents weight gain
(Rovira et al., 2008). Our results suggest that this effect might
also be mediated via inhibition of mTORC1 in adipose tissue.
raptorad/ mice are lean due to a reduction in the size and
number of adipocytes. A previous study in 3T3-L1 cells demon-
strated that rapamycin blocks adipogenesis via inhibition of the
key adipogenic transcription factor PPARg (Kim and Chen,
2004). Kim and Chen (2004) also reported that rapamycin
strongly inhibits PPARg activity in differentiated 3T3-L1 and
that incubation of differentiated 3T3-L1 with rapamycin induces
loss of fat. Our results in 3T3-L1 cells support these findings (Fig-
ures 1 and 6D). However, surprisingly, raptorad/ mice are lean
despite the absence of an effect on expression of PPARg and
PPARg targets (Figure 6E, unpublished for PPARg protein level).
Thus, in animals, there must be a mechanism(s) in addition to
mTORC1 signaling that maintains PPARg. It remains to be deter-
mined what this mechanism might be. mTORC1-deficient mice
lose fat due to increased UCP1 expression leading to enhanced
energy expenditure and not due to a PPARg deficiency. Rapa-
mycin treatment of differentiated 3T3-L1 cells did not lead to
increased UCP1 expression (data not shown), suggesting that
the effect of raptor knockout on UCP1 expression might not be
cell autonomous.
Close examination of the weight curves shows that raptorad/
mice reached a maximal weight of 30 g, regardless of being on
a chow or high-fat diet (Figure 3A). This weight was reached at
a slow, constant rate on the chow diet or very rapidly on the
high-fat diet. This observed maximal weight suggests that there
is a limit to theamountof fat that raptorad/mice canaccumulate.
This is also supported by the findings that the size of individual
adipocytes did not increase upon HFD and that the number of ad-
ipocytes was reduced in raptorad/ mice on both the chow and
high-fat diet (Figure 3E). The reason for such a fixed limit on the
amount of fat that raptorad/ mice can accumulate is unknown.
In conclusion, mTORC1 in adipose tissue regulates whole-
body metabolism and energy homeostasis. Inhibition of mTORC1
results in metabolically healthier mice, with no apparent adverse
effects. Thus, adipose mTORC1 is a potential target for antiobe-
sity and antidiabetes drugs.etabolism 8, 399–410, November 5, 2008 ª2008 Elsevier Inc. 407
Cell Metabolism
Adipose mTORC1 Controls Energy HomeostasisEXPERIMENTAL PROCEDURES
Materials
Adenoviruses encoding RNAi against raptor were created by cloning the
previously described RNAi sequence and H1 promoter (Jacinto et al., 2004)
from pSuper into pAd-DEST (Invitrogen). Empty pAd-DEST vector was used
as control. For raptor knockdown, differentiated or undifferentiated 3T3-L1
were incubated with viruses for 2 days. Antibodies for raptor were from Bethyl.
Antibodies for actin were from Chemicon. Antibodies for Akt, Akt pT308, Akt
pS473, IRS1, AMPK, and AMPK pT172 were from Cell Signaling. Rapamycin
was from LC Laboratories and was used at a concentration of 100 nM. Isopro-
terenol was from Sigma and was used at a concentration of 10 mM. Insulin,
dexamethasone, and IBMX were from Sigma.
Supplemental Experimental Procedures can be found in the Supplemental
Data available online.
SUPPLEMENTAL DATA
The Supplemental Data for this article include Supplemental Experimental Pro-
cedures and can be found with this article at http://www.cellmetabolism.org/
S1550-4131(08)00287-8.
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